+987.9%
MRNA vs QID
-21.1%
+1,009.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | QID | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -1.8% | +14.9% | +12.0% |
| 7D | +20.6% | +9.8% | +10.9% | +27.8% |
| 30D | +27.1% | +18.9% | +8.2% | +42.2% |
| 3M | +353.4% | +9.6% | +343.8% | +390.3% |
| 6M | +446.3% | -7.8% | +454.1% | +436.8% |
| YTD | +776.2% | -23.3% | +799.5% | +669.9% |
| 1Y | +987.9% | -22.0% | +1,009.9% | +874.9% |
| All | +987.9% | -21.1% | +1,009.0% | +874.9% |
Cumulative growth
Daily Returns
Daily percentage return beside QID.
Daily Out/Under-Performance
Portfolio return minus QID return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × QID return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded QID wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling